P2RY12 and Alzheimer disease: Interestingly, treating PBMCs from AD-patients with the paired CSF in vitro resulted in increased proportion of myeloid cells showing a similar phenotype as CSF-enriched myeloid cells, characterized as P2Y12+CD14+CD16+CC2low.